Opgen Inc

NASDAQ:OPGN  
2.30
+0.06 (+2.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)90.76M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.33 Million
Adjusted EPS-$0.24
See more estimates
10-Day MA$2.34
50-Day MA$2.53
200-Day MA$2.30
See more pivots

Opgen Inc Stock, NASDAQ:OPGN

708 Quince Orchard Road, Suite 250, Gaithersburg, Maryland 20878
United States of America
Phone: +1.301.869.9683
Number of Employees: 110

Description

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firms products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.